Latest Interviews
“India is supplying 70% of WHO’s vaccines requirement and will be able to bulk manufacture the Covid-19 vaccines and supply to the globe. A number of Indian companies are working on a vaccine for COVID-19, joining the global race against time to find a preventive for the deadly infection.”
57519
“The first thing producers need to know when starting a project, is how much water they have at their disposal and then they must plan an efficient management strategy that allows for responsible and secure consumption. Our purpose is to create a sustainable operation that minimizes its impact on groundwater balance.”
57517
“We prioritized INT-1B3, a lipid nanoparticle (LNP) formulated synthetic mimic of a tumor suppressor miRNA, as we found that it has a dual mode of action. Firstly, it targets tumor cells directly […] In parallel, it regulates the tumor microenvironment and ultimately elicits a long term T-cell mediated immune response.”
57515
“Analysts predict a contraction of between 8 and 10% of Mexico’s GDP, and the chemical industry will also have a contraction of around 4%. The problem we have in Mexico is that there are no fiscal or economic incentives to boost recovery.”
57513
"Some industries have performed quite well with the pandemic, in terms of polystyrene disposables for food packaging and also acrylic sheet. Besides, the agriculture industry has seen zero impact, while the demand for cyanide has remained strong, thanks to the increasing price of gold."
57511
"We do not want to be a clinical phase company at this stage of the game. We are happy to have partnerships at the IND level and let the clinical stage companies then drive it through the clinic. We think this is the best way to target pathways that might not be on the radar of big pharma and we can de-risk them by scientific review in the SBIR program."